Novo Nordisk initiates phase I trial of oral device

A new Novo Nordisk device, which is designed to be swallowed, will soon be tested in a phase I study according to the Clinical Trials database, but the pharmaceutical firm in charge does not want to divulge further details due to a scheduled quiet period.
Photo: Tidsvilde Stine/Ritzau Scanpix
Photo: Tidsvilde Stine/Ritzau Scanpix
by christopher due karlsson, translated by daniel pedersen

Novo Nordisk is taking another step on its road toward developing new technologies for oral drug delivery.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading